Retinal Drugs

Retinal Drugs Comprehensive Study by Type (Wet AMD, Diabetic Retinopathy, DME, RVO, Mcnv), Prescription Type (Prescription Ophthalmic Drugs, OTC), Distribution Channel (Hospital Pharmacies, Drug Stores, Online Pharmacies, Others) Players and Region - Global Market Outlook to 2026

Retinal Drugs Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 12.2%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Retinal is related to the retina of the eye which is a thin layer of tissue. Major causes of retinal diseases are retinal detachment, diabetic retinopathy, epiretinal membrane, macular hole, macular degeneration, and others. Some of the major symptoms of retinal diseases are seeing floating specks, blurred, defects in the side vision and lost vision. In the last few years, there is a significant increase in retinal diseases across the world. For instance, in 2016, according to an article published by American Academy of Ophthalmology, more than 93 million people had diabetic retinopathy across the worldwide, out of which more than 4.2 million patients were from the United States. Therefore, the rising number of patients across worldwide and increasing consumer buying behavior regarding retinal drugs products are some of the major factors which affect the growth of the market in the future.According to AMA, the market for Retinal Drugs is expected to register a CAGR of 12.2% during the forecast period to 2026. This growth is primarily driven by Rising Old Population and Corresponding Increase in Technology Advancement of Retinal Drugs across the World and Increasing Number of Patients Regarding the Incidence of Eye-Related Diseases.

Globally, a noticeable market trend is evident One of the latest trends of this Market is Increasing Usage of Combination Therapies. The Pharmaceuticals sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Bayer AG (Germany), F. Hoffmann-La Roche (Switzerland), Bausch & Lomb (United States), Novartis International AG (Switzerland), Regeneron Pharmaceuticals, Inc. (United States), Johnson and Johnson Vision (United States), Merck & Co. (United States), Shire Plc (Untied States), Janssen Biotech, Inc. (United States) and Teva Pharmaceutical Industries Ltd. (Israel) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

In January 2019, the Santen Pharmaceutical Co., Ltd. (Japan) company has planned to products for retinal disease and glaucoma. Hence, this launched will benefit increase in the product portfolio of the company.

Market Drivers
  • Rising Old Population and Corresponding Increase in Technology Advancement of Retinal Drugs across the World
  • Increasing Number of Patients Regarding the Incidence of Eye-Related Diseases

Market Trend
  • One of the latest trends of this Market is Increasing Usage of Combination Therapies

Restraints
  • Issue related to Risk of Side Effects associated with Retinal Drugs

Opportunities
Mounting Demand from Emerging Economics such as China, India, Brazil, among others and Government Initiative for the Treatment of Retinal Diseases
Challenges
The problem regarding the Shortage of trained professionals

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Retinal Drugs Study Sheds Light on
— The Retinal Drugs Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Retinal Drugs industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Retinal Drugs industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Wet AMD
  • Diabetic Retinopathy
  • DME
  • RVO
  • Mcnv
By Prescription Type
  • Prescription Ophthalmic Drugs
  • OTC

By Distribution Channel
  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Old Population and Corresponding Increase in Technology Advancement of Retinal Drugs across the World
      • 3.2.2. Increasing Number of Patients Regarding the Incidence of Eye-Related Diseases
    • 3.3. Market Challenges
      • 3.3.1. The problem regarding the Shortage of trained professionals
    • 3.4. Market Trends
      • 3.4.1. One of the latest trends of this Market is Increasing Usage of Combination Therapies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Retinal Drugs, by Type, Prescription Type, Distribution Channel and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Retinal Drugs (Value)
      • 5.2.1. Global Retinal Drugs by: Type (Value)
        • 5.2.1.1. Wet AMD
        • 5.2.1.2. Diabetic Retinopathy
        • 5.2.1.3. DME
        • 5.2.1.4. RVO
        • 5.2.1.5. Mcnv
      • 5.2.2. Global Retinal Drugs by: Prescription Type (Value)
        • 5.2.2.1. Prescription Ophthalmic Drugs
        • 5.2.2.2. OTC
      • 5.2.3. Global Retinal Drugs by: Distribution Channel (Value)
        • 5.2.3.1. Hospital Pharmacies
        • 5.2.3.2. Drug Stores
        • 5.2.3.3. Online Pharmacies
        • 5.2.3.4. Others
      • 5.2.4. Global Retinal Drugs Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Retinal Drugs (Volume)
      • 5.3.1. Global Retinal Drugs by: Type (Volume)
        • 5.3.1.1. Wet AMD
        • 5.3.1.2. Diabetic Retinopathy
        • 5.3.1.3. DME
        • 5.3.1.4. RVO
        • 5.3.1.5. Mcnv
      • 5.3.2. Global Retinal Drugs by: Prescription Type (Volume)
        • 5.3.2.1. Prescription Ophthalmic Drugs
        • 5.3.2.2. OTC
      • 5.3.3. Global Retinal Drugs by: Distribution Channel (Volume)
        • 5.3.3.1. Hospital Pharmacies
        • 5.3.3.2. Drug Stores
        • 5.3.3.3. Online Pharmacies
        • 5.3.3.4. Others
      • 5.3.4. Global Retinal Drugs Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Retinal Drugs (Price)
      • 5.4.1. Global Retinal Drugs by: Type (Price)
  • 6. Retinal Drugs: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bayer AG (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. F. Hoffmann-La Roche (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Bausch & Lomb (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Novartis International AG (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Regeneron Pharmaceuticals, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Johnson and Johnson Vision (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Merck & Co. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Shire Plc (Untied States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Janssen Biotech, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Teva Pharmaceutical Industries Ltd. (Israel)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Retinal Drugs Sale, by Type, Prescription Type, Distribution Channel and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Retinal Drugs (Value)
      • 7.2.1. Global Retinal Drugs by: Type (Value)
        • 7.2.1.1. Wet AMD
        • 7.2.1.2. Diabetic Retinopathy
        • 7.2.1.3. DME
        • 7.2.1.4. RVO
        • 7.2.1.5. Mcnv
      • 7.2.2. Global Retinal Drugs by: Prescription Type (Value)
        • 7.2.2.1. Prescription Ophthalmic Drugs
        • 7.2.2.2. OTC
      • 7.2.3. Global Retinal Drugs by: Distribution Channel (Value)
        • 7.2.3.1. Hospital Pharmacies
        • 7.2.3.2. Drug Stores
        • 7.2.3.3. Online Pharmacies
        • 7.2.3.4. Others
      • 7.2.4. Global Retinal Drugs Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Retinal Drugs (Volume)
      • 7.3.1. Global Retinal Drugs by: Type (Volume)
        • 7.3.1.1. Wet AMD
        • 7.3.1.2. Diabetic Retinopathy
        • 7.3.1.3. DME
        • 7.3.1.4. RVO
        • 7.3.1.5. Mcnv
      • 7.3.2. Global Retinal Drugs by: Prescription Type (Volume)
        • 7.3.2.1. Prescription Ophthalmic Drugs
        • 7.3.2.2. OTC
      • 7.3.3. Global Retinal Drugs by: Distribution Channel (Volume)
        • 7.3.3.1. Hospital Pharmacies
        • 7.3.3.2. Drug Stores
        • 7.3.3.3. Online Pharmacies
        • 7.3.3.4. Others
      • 7.3.4. Global Retinal Drugs Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Retinal Drugs (Price)
      • 7.4.1. Global Retinal Drugs by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Retinal Drugs: by Type(USD Million)
  • Table 2. Retinal Drugs Wet AMD , by Region USD Million (2015-2020)
  • Table 3. Retinal Drugs Diabetic Retinopathy , by Region USD Million (2015-2020)
  • Table 4. Retinal Drugs DME , by Region USD Million (2015-2020)
  • Table 5. Retinal Drugs RVO , by Region USD Million (2015-2020)
  • Table 6. Retinal Drugs Mcnv , by Region USD Million (2015-2020)
  • Table 7. Retinal Drugs: by Prescription Type(USD Million)
  • Table 8. Retinal Drugs Prescription Ophthalmic Drugs , by Region USD Million (2015-2020)
  • Table 9. Retinal Drugs OTC , by Region USD Million (2015-2020)
  • Table 10. Retinal Drugs: by Distribution Channel(USD Million)
  • Table 11. Retinal Drugs Hospital Pharmacies , by Region USD Million (2015-2020)
  • Table 12. Retinal Drugs Drug Stores , by Region USD Million (2015-2020)
  • Table 13. Retinal Drugs Online Pharmacies , by Region USD Million (2015-2020)
  • Table 14. Retinal Drugs Others , by Region USD Million (2015-2020)
  • Table 15. South America Retinal Drugs, by Country USD Million (2015-2020)
  • Table 16. South America Retinal Drugs, by Type USD Million (2015-2020)
  • Table 17. South America Retinal Drugs, by Prescription Type USD Million (2015-2020)
  • Table 18. South America Retinal Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 19. Brazil Retinal Drugs, by Type USD Million (2015-2020)
  • Table 20. Brazil Retinal Drugs, by Prescription Type USD Million (2015-2020)
  • Table 21. Brazil Retinal Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 22. Argentina Retinal Drugs, by Type USD Million (2015-2020)
  • Table 23. Argentina Retinal Drugs, by Prescription Type USD Million (2015-2020)
  • Table 24. Argentina Retinal Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 25. Rest of South America Retinal Drugs, by Type USD Million (2015-2020)
  • Table 26. Rest of South America Retinal Drugs, by Prescription Type USD Million (2015-2020)
  • Table 27. Rest of South America Retinal Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 28. Asia Pacific Retinal Drugs, by Country USD Million (2015-2020)
  • Table 29. Asia Pacific Retinal Drugs, by Type USD Million (2015-2020)
  • Table 30. Asia Pacific Retinal Drugs, by Prescription Type USD Million (2015-2020)
  • Table 31. Asia Pacific Retinal Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 32. China Retinal Drugs, by Type USD Million (2015-2020)
  • Table 33. China Retinal Drugs, by Prescription Type USD Million (2015-2020)
  • Table 34. China Retinal Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 35. Japan Retinal Drugs, by Type USD Million (2015-2020)
  • Table 36. Japan Retinal Drugs, by Prescription Type USD Million (2015-2020)
  • Table 37. Japan Retinal Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 38. India Retinal Drugs, by Type USD Million (2015-2020)
  • Table 39. India Retinal Drugs, by Prescription Type USD Million (2015-2020)
  • Table 40. India Retinal Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 41. South Korea Retinal Drugs, by Type USD Million (2015-2020)
  • Table 42. South Korea Retinal Drugs, by Prescription Type USD Million (2015-2020)
  • Table 43. South Korea Retinal Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 44. Taiwan Retinal Drugs, by Type USD Million (2015-2020)
  • Table 45. Taiwan Retinal Drugs, by Prescription Type USD Million (2015-2020)
  • Table 46. Taiwan Retinal Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 47. Australia Retinal Drugs, by Type USD Million (2015-2020)
  • Table 48. Australia Retinal Drugs, by Prescription Type USD Million (2015-2020)
  • Table 49. Australia Retinal Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 50. Rest of Asia-Pacific Retinal Drugs, by Type USD Million (2015-2020)
  • Table 51. Rest of Asia-Pacific Retinal Drugs, by Prescription Type USD Million (2015-2020)
  • Table 52. Rest of Asia-Pacific Retinal Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 53. Europe Retinal Drugs, by Country USD Million (2015-2020)
  • Table 54. Europe Retinal Drugs, by Type USD Million (2015-2020)
  • Table 55. Europe Retinal Drugs, by Prescription Type USD Million (2015-2020)
  • Table 56. Europe Retinal Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 57. Germany Retinal Drugs, by Type USD Million (2015-2020)
  • Table 58. Germany Retinal Drugs, by Prescription Type USD Million (2015-2020)
  • Table 59. Germany Retinal Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 60. France Retinal Drugs, by Type USD Million (2015-2020)
  • Table 61. France Retinal Drugs, by Prescription Type USD Million (2015-2020)
  • Table 62. France Retinal Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 63. Italy Retinal Drugs, by Type USD Million (2015-2020)
  • Table 64. Italy Retinal Drugs, by Prescription Type USD Million (2015-2020)
  • Table 65. Italy Retinal Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 66. United Kingdom Retinal Drugs, by Type USD Million (2015-2020)
  • Table 67. United Kingdom Retinal Drugs, by Prescription Type USD Million (2015-2020)
  • Table 68. United Kingdom Retinal Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 69. Netherlands Retinal Drugs, by Type USD Million (2015-2020)
  • Table 70. Netherlands Retinal Drugs, by Prescription Type USD Million (2015-2020)
  • Table 71. Netherlands Retinal Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 72. Rest of Europe Retinal Drugs, by Type USD Million (2015-2020)
  • Table 73. Rest of Europe Retinal Drugs, by Prescription Type USD Million (2015-2020)
  • Table 74. Rest of Europe Retinal Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 75. MEA Retinal Drugs, by Country USD Million (2015-2020)
  • Table 76. MEA Retinal Drugs, by Type USD Million (2015-2020)
  • Table 77. MEA Retinal Drugs, by Prescription Type USD Million (2015-2020)
  • Table 78. MEA Retinal Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 79. Middle East Retinal Drugs, by Type USD Million (2015-2020)
  • Table 80. Middle East Retinal Drugs, by Prescription Type USD Million (2015-2020)
  • Table 81. Middle East Retinal Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 82. Africa Retinal Drugs, by Type USD Million (2015-2020)
  • Table 83. Africa Retinal Drugs, by Prescription Type USD Million (2015-2020)
  • Table 84. Africa Retinal Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 85. North America Retinal Drugs, by Country USD Million (2015-2020)
  • Table 86. North America Retinal Drugs, by Type USD Million (2015-2020)
  • Table 87. North America Retinal Drugs, by Prescription Type USD Million (2015-2020)
  • Table 88. North America Retinal Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 89. United States Retinal Drugs, by Type USD Million (2015-2020)
  • Table 90. United States Retinal Drugs, by Prescription Type USD Million (2015-2020)
  • Table 91. United States Retinal Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 92. Canada Retinal Drugs, by Type USD Million (2015-2020)
  • Table 93. Canada Retinal Drugs, by Prescription Type USD Million (2015-2020)
  • Table 94. Canada Retinal Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 95. Mexico Retinal Drugs, by Type USD Million (2015-2020)
  • Table 96. Mexico Retinal Drugs, by Prescription Type USD Million (2015-2020)
  • Table 97. Mexico Retinal Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 98. Retinal Drugs Sales: by Type(k Units)
  • Table 99. Retinal Drugs Sales Wet AMD , by Region k Units (2015-2020)
  • Table 100. Retinal Drugs Sales Diabetic Retinopathy , by Region k Units (2015-2020)
  • Table 101. Retinal Drugs Sales DME , by Region k Units (2015-2020)
  • Table 102. Retinal Drugs Sales RVO , by Region k Units (2015-2020)
  • Table 103. Retinal Drugs Sales Mcnv , by Region k Units (2015-2020)
  • Table 104. Retinal Drugs Sales: by Prescription Type(k Units)
  • Table 105. Retinal Drugs Sales Prescription Ophthalmic Drugs , by Region k Units (2015-2020)
  • Table 106. Retinal Drugs Sales OTC , by Region k Units (2015-2020)
  • Table 107. Retinal Drugs Sales: by Distribution Channel(k Units)
  • Table 108. Retinal Drugs Sales Hospital Pharmacies , by Region k Units (2015-2020)
  • Table 109. Retinal Drugs Sales Drug Stores , by Region k Units (2015-2020)
  • Table 110. Retinal Drugs Sales Online Pharmacies , by Region k Units (2015-2020)
  • Table 111. Retinal Drugs Sales Others , by Region k Units (2015-2020)
  • Table 112. South America Retinal Drugs Sales, by Country k Units (2015-2020)
  • Table 113. South America Retinal Drugs Sales, by Type k Units (2015-2020)
  • Table 114. South America Retinal Drugs Sales, by Prescription Type k Units (2015-2020)
  • Table 115. South America Retinal Drugs Sales, by Distribution Channel k Units (2015-2020)
  • Table 116. Brazil Retinal Drugs Sales, by Type k Units (2015-2020)
  • Table 117. Brazil Retinal Drugs Sales, by Prescription Type k Units (2015-2020)
  • Table 118. Brazil Retinal Drugs Sales, by Distribution Channel k Units (2015-2020)
  • Table 119. Argentina Retinal Drugs Sales, by Type k Units (2015-2020)
  • Table 120. Argentina Retinal Drugs Sales, by Prescription Type k Units (2015-2020)
  • Table 121. Argentina Retinal Drugs Sales, by Distribution Channel k Units (2015-2020)
  • Table 122. Rest of South America Retinal Drugs Sales, by Type k Units (2015-2020)
  • Table 123. Rest of South America Retinal Drugs Sales, by Prescription Type k Units (2015-2020)
  • Table 124. Rest of South America Retinal Drugs Sales, by Distribution Channel k Units (2015-2020)
  • Table 125. Asia Pacific Retinal Drugs Sales, by Country k Units (2015-2020)
  • Table 126. Asia Pacific Retinal Drugs Sales, by Type k Units (2015-2020)
  • Table 127. Asia Pacific Retinal Drugs Sales, by Prescription Type k Units (2015-2020)
  • Table 128. Asia Pacific Retinal Drugs Sales, by Distribution Channel k Units (2015-2020)
  • Table 129. China Retinal Drugs Sales, by Type k Units (2015-2020)
  • Table 130. China Retinal Drugs Sales, by Prescription Type k Units (2015-2020)
  • Table 131. China Retinal Drugs Sales, by Distribution Channel k Units (2015-2020)
  • Table 132. Japan Retinal Drugs Sales, by Type k Units (2015-2020)
  • Table 133. Japan Retinal Drugs Sales, by Prescription Type k Units (2015-2020)
  • Table 134. Japan Retinal Drugs Sales, by Distribution Channel k Units (2015-2020)
  • Table 135. India Retinal Drugs Sales, by Type k Units (2015-2020)
  • Table 136. India Retinal Drugs Sales, by Prescription Type k Units (2015-2020)
  • Table 137. India Retinal Drugs Sales, by Distribution Channel k Units (2015-2020)
  • Table 138. South Korea Retinal Drugs Sales, by Type k Units (2015-2020)
  • Table 139. South Korea Retinal Drugs Sales, by Prescription Type k Units (2015-2020)
  • Table 140. South Korea Retinal Drugs Sales, by Distribution Channel k Units (2015-2020)
  • Table 141. Taiwan Retinal Drugs Sales, by Type k Units (2015-2020)
  • Table 142. Taiwan Retinal Drugs Sales, by Prescription Type k Units (2015-2020)
  • Table 143. Taiwan Retinal Drugs Sales, by Distribution Channel k Units (2015-2020)
  • Table 144. Australia Retinal Drugs Sales, by Type k Units (2015-2020)
  • Table 145. Australia Retinal Drugs Sales, by Prescription Type k Units (2015-2020)
  • Table 146. Australia Retinal Drugs Sales, by Distribution Channel k Units (2015-2020)
  • Table 147. Rest of Asia-Pacific Retinal Drugs Sales, by Type k Units (2015-2020)
  • Table 148. Rest of Asia-Pacific Retinal Drugs Sales, by Prescription Type k Units (2015-2020)
  • Table 149. Rest of Asia-Pacific Retinal Drugs Sales, by Distribution Channel k Units (2015-2020)
  • Table 150. Europe Retinal Drugs Sales, by Country k Units (2015-2020)
  • Table 151. Europe Retinal Drugs Sales, by Type k Units (2015-2020)
  • Table 152. Europe Retinal Drugs Sales, by Prescription Type k Units (2015-2020)
  • Table 153. Europe Retinal Drugs Sales, by Distribution Channel k Units (2015-2020)
  • Table 154. Germany Retinal Drugs Sales, by Type k Units (2015-2020)
  • Table 155. Germany Retinal Drugs Sales, by Prescription Type k Units (2015-2020)
  • Table 156. Germany Retinal Drugs Sales, by Distribution Channel k Units (2015-2020)
  • Table 157. France Retinal Drugs Sales, by Type k Units (2015-2020)
  • Table 158. France Retinal Drugs Sales, by Prescription Type k Units (2015-2020)
  • Table 159. France Retinal Drugs Sales, by Distribution Channel k Units (2015-2020)
  • Table 160. Italy Retinal Drugs Sales, by Type k Units (2015-2020)
  • Table 161. Italy Retinal Drugs Sales, by Prescription Type k Units (2015-2020)
  • Table 162. Italy Retinal Drugs Sales, by Distribution Channel k Units (2015-2020)
  • Table 163. United Kingdom Retinal Drugs Sales, by Type k Units (2015-2020)
  • Table 164. United Kingdom Retinal Drugs Sales, by Prescription Type k Units (2015-2020)
  • Table 165. United Kingdom Retinal Drugs Sales, by Distribution Channel k Units (2015-2020)
  • Table 166. Netherlands Retinal Drugs Sales, by Type k Units (2015-2020)
  • Table 167. Netherlands Retinal Drugs Sales, by Prescription Type k Units (2015-2020)
  • Table 168. Netherlands Retinal Drugs Sales, by Distribution Channel k Units (2015-2020)
  • Table 169. Rest of Europe Retinal Drugs Sales, by Type k Units (2015-2020)
  • Table 170. Rest of Europe Retinal Drugs Sales, by Prescription Type k Units (2015-2020)
  • Table 171. Rest of Europe Retinal Drugs Sales, by Distribution Channel k Units (2015-2020)
  • Table 172. MEA Retinal Drugs Sales, by Country k Units (2015-2020)
  • Table 173. MEA Retinal Drugs Sales, by Type k Units (2015-2020)
  • Table 174. MEA Retinal Drugs Sales, by Prescription Type k Units (2015-2020)
  • Table 175. MEA Retinal Drugs Sales, by Distribution Channel k Units (2015-2020)
  • Table 176. Middle East Retinal Drugs Sales, by Type k Units (2015-2020)
  • Table 177. Middle East Retinal Drugs Sales, by Prescription Type k Units (2015-2020)
  • Table 178. Middle East Retinal Drugs Sales, by Distribution Channel k Units (2015-2020)
  • Table 179. Africa Retinal Drugs Sales, by Type k Units (2015-2020)
  • Table 180. Africa Retinal Drugs Sales, by Prescription Type k Units (2015-2020)
  • Table 181. Africa Retinal Drugs Sales, by Distribution Channel k Units (2015-2020)
  • Table 182. North America Retinal Drugs Sales, by Country k Units (2015-2020)
  • Table 183. North America Retinal Drugs Sales, by Type k Units (2015-2020)
  • Table 184. North America Retinal Drugs Sales, by Prescription Type k Units (2015-2020)
  • Table 185. North America Retinal Drugs Sales, by Distribution Channel k Units (2015-2020)
  • Table 186. United States Retinal Drugs Sales, by Type k Units (2015-2020)
  • Table 187. United States Retinal Drugs Sales, by Prescription Type k Units (2015-2020)
  • Table 188. United States Retinal Drugs Sales, by Distribution Channel k Units (2015-2020)
  • Table 189. Canada Retinal Drugs Sales, by Type k Units (2015-2020)
  • Table 190. Canada Retinal Drugs Sales, by Prescription Type k Units (2015-2020)
  • Table 191. Canada Retinal Drugs Sales, by Distribution Channel k Units (2015-2020)
  • Table 192. Mexico Retinal Drugs Sales, by Type k Units (2015-2020)
  • Table 193. Mexico Retinal Drugs Sales, by Prescription Type k Units (2015-2020)
  • Table 194. Mexico Retinal Drugs Sales, by Distribution Channel k Units (2015-2020)
  • Table 195. Retinal Drugs: by Type(USD/Units)
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Retinal Drugs: by Type(USD Million)
  • Table 207. Retinal Drugs Wet AMD , by Region USD Million (2021-2026)
  • Table 208. Retinal Drugs Diabetic Retinopathy , by Region USD Million (2021-2026)
  • Table 209. Retinal Drugs DME , by Region USD Million (2021-2026)
  • Table 210. Retinal Drugs RVO , by Region USD Million (2021-2026)
  • Table 211. Retinal Drugs Mcnv , by Region USD Million (2021-2026)
  • Table 212. Retinal Drugs: by Prescription Type(USD Million)
  • Table 213. Retinal Drugs Prescription Ophthalmic Drugs , by Region USD Million (2021-2026)
  • Table 214. Retinal Drugs OTC , by Region USD Million (2021-2026)
  • Table 215. Retinal Drugs: by Distribution Channel(USD Million)
  • Table 216. Retinal Drugs Hospital Pharmacies , by Region USD Million (2021-2026)
  • Table 217. Retinal Drugs Drug Stores , by Region USD Million (2021-2026)
  • Table 218. Retinal Drugs Online Pharmacies , by Region USD Million (2021-2026)
  • Table 219. Retinal Drugs Others , by Region USD Million (2021-2026)
  • Table 220. South America Retinal Drugs, by Country USD Million (2021-2026)
  • Table 221. South America Retinal Drugs, by Type USD Million (2021-2026)
  • Table 222. South America Retinal Drugs, by Prescription Type USD Million (2021-2026)
  • Table 223. South America Retinal Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 224. Brazil Retinal Drugs, by Type USD Million (2021-2026)
  • Table 225. Brazil Retinal Drugs, by Prescription Type USD Million (2021-2026)
  • Table 226. Brazil Retinal Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 227. Argentina Retinal Drugs, by Type USD Million (2021-2026)
  • Table 228. Argentina Retinal Drugs, by Prescription Type USD Million (2021-2026)
  • Table 229. Argentina Retinal Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 230. Rest of South America Retinal Drugs, by Type USD Million (2021-2026)
  • Table 231. Rest of South America Retinal Drugs, by Prescription Type USD Million (2021-2026)
  • Table 232. Rest of South America Retinal Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 233. Asia Pacific Retinal Drugs, by Country USD Million (2021-2026)
  • Table 234. Asia Pacific Retinal Drugs, by Type USD Million (2021-2026)
  • Table 235. Asia Pacific Retinal Drugs, by Prescription Type USD Million (2021-2026)
  • Table 236. Asia Pacific Retinal Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 237. China Retinal Drugs, by Type USD Million (2021-2026)
  • Table 238. China Retinal Drugs, by Prescription Type USD Million (2021-2026)
  • Table 239. China Retinal Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 240. Japan Retinal Drugs, by Type USD Million (2021-2026)
  • Table 241. Japan Retinal Drugs, by Prescription Type USD Million (2021-2026)
  • Table 242. Japan Retinal Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 243. India Retinal Drugs, by Type USD Million (2021-2026)
  • Table 244. India Retinal Drugs, by Prescription Type USD Million (2021-2026)
  • Table 245. India Retinal Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 246. South Korea Retinal Drugs, by Type USD Million (2021-2026)
  • Table 247. South Korea Retinal Drugs, by Prescription Type USD Million (2021-2026)
  • Table 248. South Korea Retinal Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 249. Taiwan Retinal Drugs, by Type USD Million (2021-2026)
  • Table 250. Taiwan Retinal Drugs, by Prescription Type USD Million (2021-2026)
  • Table 251. Taiwan Retinal Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 252. Australia Retinal Drugs, by Type USD Million (2021-2026)
  • Table 253. Australia Retinal Drugs, by Prescription Type USD Million (2021-2026)
  • Table 254. Australia Retinal Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 255. Rest of Asia-Pacific Retinal Drugs, by Type USD Million (2021-2026)
  • Table 256. Rest of Asia-Pacific Retinal Drugs, by Prescription Type USD Million (2021-2026)
  • Table 257. Rest of Asia-Pacific Retinal Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 258. Europe Retinal Drugs, by Country USD Million (2021-2026)
  • Table 259. Europe Retinal Drugs, by Type USD Million (2021-2026)
  • Table 260. Europe Retinal Drugs, by Prescription Type USD Million (2021-2026)
  • Table 261. Europe Retinal Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 262. Germany Retinal Drugs, by Type USD Million (2021-2026)
  • Table 263. Germany Retinal Drugs, by Prescription Type USD Million (2021-2026)
  • Table 264. Germany Retinal Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 265. France Retinal Drugs, by Type USD Million (2021-2026)
  • Table 266. France Retinal Drugs, by Prescription Type USD Million (2021-2026)
  • Table 267. France Retinal Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 268. Italy Retinal Drugs, by Type USD Million (2021-2026)
  • Table 269. Italy Retinal Drugs, by Prescription Type USD Million (2021-2026)
  • Table 270. Italy Retinal Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 271. United Kingdom Retinal Drugs, by Type USD Million (2021-2026)
  • Table 272. United Kingdom Retinal Drugs, by Prescription Type USD Million (2021-2026)
  • Table 273. United Kingdom Retinal Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 274. Netherlands Retinal Drugs, by Type USD Million (2021-2026)
  • Table 275. Netherlands Retinal Drugs, by Prescription Type USD Million (2021-2026)
  • Table 276. Netherlands Retinal Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 277. Rest of Europe Retinal Drugs, by Type USD Million (2021-2026)
  • Table 278. Rest of Europe Retinal Drugs, by Prescription Type USD Million (2021-2026)
  • Table 279. Rest of Europe Retinal Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 280. MEA Retinal Drugs, by Country USD Million (2021-2026)
  • Table 281. MEA Retinal Drugs, by Type USD Million (2021-2026)
  • Table 282. MEA Retinal Drugs, by Prescription Type USD Million (2021-2026)
  • Table 283. MEA Retinal Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 284. Middle East Retinal Drugs, by Type USD Million (2021-2026)
  • Table 285. Middle East Retinal Drugs, by Prescription Type USD Million (2021-2026)
  • Table 286. Middle East Retinal Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 287. Africa Retinal Drugs, by Type USD Million (2021-2026)
  • Table 288. Africa Retinal Drugs, by Prescription Type USD Million (2021-2026)
  • Table 289. Africa Retinal Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 290. North America Retinal Drugs, by Country USD Million (2021-2026)
  • Table 291. North America Retinal Drugs, by Type USD Million (2021-2026)
  • Table 292. North America Retinal Drugs, by Prescription Type USD Million (2021-2026)
  • Table 293. North America Retinal Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 294. United States Retinal Drugs, by Type USD Million (2021-2026)
  • Table 295. United States Retinal Drugs, by Prescription Type USD Million (2021-2026)
  • Table 296. United States Retinal Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 297. Canada Retinal Drugs, by Type USD Million (2021-2026)
  • Table 298. Canada Retinal Drugs, by Prescription Type USD Million (2021-2026)
  • Table 299. Canada Retinal Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 300. Mexico Retinal Drugs, by Type USD Million (2021-2026)
  • Table 301. Mexico Retinal Drugs, by Prescription Type USD Million (2021-2026)
  • Table 302. Mexico Retinal Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 303. Retinal Drugs Sales: by Type(k Units)
  • Table 304. Retinal Drugs Sales Wet AMD , by Region k Units (2021-2026)
  • Table 305. Retinal Drugs Sales Diabetic Retinopathy , by Region k Units (2021-2026)
  • Table 306. Retinal Drugs Sales DME , by Region k Units (2021-2026)
  • Table 307. Retinal Drugs Sales RVO , by Region k Units (2021-2026)
  • Table 308. Retinal Drugs Sales Mcnv , by Region k Units (2021-2026)
  • Table 309. Retinal Drugs Sales: by Prescription Type(k Units)
  • Table 310. Retinal Drugs Sales Prescription Ophthalmic Drugs , by Region k Units (2021-2026)
  • Table 311. Retinal Drugs Sales OTC , by Region k Units (2021-2026)
  • Table 312. Retinal Drugs Sales: by Distribution Channel(k Units)
  • Table 313. Retinal Drugs Sales Hospital Pharmacies , by Region k Units (2021-2026)
  • Table 314. Retinal Drugs Sales Drug Stores , by Region k Units (2021-2026)
  • Table 315. Retinal Drugs Sales Online Pharmacies , by Region k Units (2021-2026)
  • Table 316. Retinal Drugs Sales Others , by Region k Units (2021-2026)
  • Table 317. South America Retinal Drugs Sales, by Country k Units (2021-2026)
  • Table 318. South America Retinal Drugs Sales, by Type k Units (2021-2026)
  • Table 319. South America Retinal Drugs Sales, by Prescription Type k Units (2021-2026)
  • Table 320. South America Retinal Drugs Sales, by Distribution Channel k Units (2021-2026)
  • Table 321. Brazil Retinal Drugs Sales, by Type k Units (2021-2026)
  • Table 322. Brazil Retinal Drugs Sales, by Prescription Type k Units (2021-2026)
  • Table 323. Brazil Retinal Drugs Sales, by Distribution Channel k Units (2021-2026)
  • Table 324. Argentina Retinal Drugs Sales, by Type k Units (2021-2026)
  • Table 325. Argentina Retinal Drugs Sales, by Prescription Type k Units (2021-2026)
  • Table 326. Argentina Retinal Drugs Sales, by Distribution Channel k Units (2021-2026)
  • Table 327. Rest of South America Retinal Drugs Sales, by Type k Units (2021-2026)
  • Table 328. Rest of South America Retinal Drugs Sales, by Prescription Type k Units (2021-2026)
  • Table 329. Rest of South America Retinal Drugs Sales, by Distribution Channel k Units (2021-2026)
  • Table 330. Asia Pacific Retinal Drugs Sales, by Country k Units (2021-2026)
  • Table 331. Asia Pacific Retinal Drugs Sales, by Type k Units (2021-2026)
  • Table 332. Asia Pacific Retinal Drugs Sales, by Prescription Type k Units (2021-2026)
  • Table 333. Asia Pacific Retinal Drugs Sales, by Distribution Channel k Units (2021-2026)
  • Table 334. China Retinal Drugs Sales, by Type k Units (2021-2026)
  • Table 335. China Retinal Drugs Sales, by Prescription Type k Units (2021-2026)
  • Table 336. China Retinal Drugs Sales, by Distribution Channel k Units (2021-2026)
  • Table 337. Japan Retinal Drugs Sales, by Type k Units (2021-2026)
  • Table 338. Japan Retinal Drugs Sales, by Prescription Type k Units (2021-2026)
  • Table 339. Japan Retinal Drugs Sales, by Distribution Channel k Units (2021-2026)
  • Table 340. India Retinal Drugs Sales, by Type k Units (2021-2026)
  • Table 341. India Retinal Drugs Sales, by Prescription Type k Units (2021-2026)
  • Table 342. India Retinal Drugs Sales, by Distribution Channel k Units (2021-2026)
  • Table 343. South Korea Retinal Drugs Sales, by Type k Units (2021-2026)
  • Table 344. South Korea Retinal Drugs Sales, by Prescription Type k Units (2021-2026)
  • Table 345. South Korea Retinal Drugs Sales, by Distribution Channel k Units (2021-2026)
  • Table 346. Taiwan Retinal Drugs Sales, by Type k Units (2021-2026)
  • Table 347. Taiwan Retinal Drugs Sales, by Prescription Type k Units (2021-2026)
  • Table 348. Taiwan Retinal Drugs Sales, by Distribution Channel k Units (2021-2026)
  • Table 349. Australia Retinal Drugs Sales, by Type k Units (2021-2026)
  • Table 350. Australia Retinal Drugs Sales, by Prescription Type k Units (2021-2026)
  • Table 351. Australia Retinal Drugs Sales, by Distribution Channel k Units (2021-2026)
  • Table 352. Rest of Asia-Pacific Retinal Drugs Sales, by Type k Units (2021-2026)
  • Table 353. Rest of Asia-Pacific Retinal Drugs Sales, by Prescription Type k Units (2021-2026)
  • Table 354. Rest of Asia-Pacific Retinal Drugs Sales, by Distribution Channel k Units (2021-2026)
  • Table 355. Europe Retinal Drugs Sales, by Country k Units (2021-2026)
  • Table 356. Europe Retinal Drugs Sales, by Type k Units (2021-2026)
  • Table 357. Europe Retinal Drugs Sales, by Prescription Type k Units (2021-2026)
  • Table 358. Europe Retinal Drugs Sales, by Distribution Channel k Units (2021-2026)
  • Table 359. Germany Retinal Drugs Sales, by Type k Units (2021-2026)
  • Table 360. Germany Retinal Drugs Sales, by Prescription Type k Units (2021-2026)
  • Table 361. Germany Retinal Drugs Sales, by Distribution Channel k Units (2021-2026)
  • Table 362. France Retinal Drugs Sales, by Type k Units (2021-2026)
  • Table 363. France Retinal Drugs Sales, by Prescription Type k Units (2021-2026)
  • Table 364. France Retinal Drugs Sales, by Distribution Channel k Units (2021-2026)
  • Table 365. Italy Retinal Drugs Sales, by Type k Units (2021-2026)
  • Table 366. Italy Retinal Drugs Sales, by Prescription Type k Units (2021-2026)
  • Table 367. Italy Retinal Drugs Sales, by Distribution Channel k Units (2021-2026)
  • Table 368. United Kingdom Retinal Drugs Sales, by Type k Units (2021-2026)
  • Table 369. United Kingdom Retinal Drugs Sales, by Prescription Type k Units (2021-2026)
  • Table 370. United Kingdom Retinal Drugs Sales, by Distribution Channel k Units (2021-2026)
  • Table 371. Netherlands Retinal Drugs Sales, by Type k Units (2021-2026)
  • Table 372. Netherlands Retinal Drugs Sales, by Prescription Type k Units (2021-2026)
  • Table 373. Netherlands Retinal Drugs Sales, by Distribution Channel k Units (2021-2026)
  • Table 374. Rest of Europe Retinal Drugs Sales, by Type k Units (2021-2026)
  • Table 375. Rest of Europe Retinal Drugs Sales, by Prescription Type k Units (2021-2026)
  • Table 376. Rest of Europe Retinal Drugs Sales, by Distribution Channel k Units (2021-2026)
  • Table 377. MEA Retinal Drugs Sales, by Country k Units (2021-2026)
  • Table 378. MEA Retinal Drugs Sales, by Type k Units (2021-2026)
  • Table 379. MEA Retinal Drugs Sales, by Prescription Type k Units (2021-2026)
  • Table 380. MEA Retinal Drugs Sales, by Distribution Channel k Units (2021-2026)
  • Table 381. Middle East Retinal Drugs Sales, by Type k Units (2021-2026)
  • Table 382. Middle East Retinal Drugs Sales, by Prescription Type k Units (2021-2026)
  • Table 383. Middle East Retinal Drugs Sales, by Distribution Channel k Units (2021-2026)
  • Table 384. Africa Retinal Drugs Sales, by Type k Units (2021-2026)
  • Table 385. Africa Retinal Drugs Sales, by Prescription Type k Units (2021-2026)
  • Table 386. Africa Retinal Drugs Sales, by Distribution Channel k Units (2021-2026)
  • Table 387. North America Retinal Drugs Sales, by Country k Units (2021-2026)
  • Table 388. North America Retinal Drugs Sales, by Type k Units (2021-2026)
  • Table 389. North America Retinal Drugs Sales, by Prescription Type k Units (2021-2026)
  • Table 390. North America Retinal Drugs Sales, by Distribution Channel k Units (2021-2026)
  • Table 391. United States Retinal Drugs Sales, by Type k Units (2021-2026)
  • Table 392. United States Retinal Drugs Sales, by Prescription Type k Units (2021-2026)
  • Table 393. United States Retinal Drugs Sales, by Distribution Channel k Units (2021-2026)
  • Table 394. Canada Retinal Drugs Sales, by Type k Units (2021-2026)
  • Table 395. Canada Retinal Drugs Sales, by Prescription Type k Units (2021-2026)
  • Table 396. Canada Retinal Drugs Sales, by Distribution Channel k Units (2021-2026)
  • Table 397. Mexico Retinal Drugs Sales, by Type k Units (2021-2026)
  • Table 398. Mexico Retinal Drugs Sales, by Prescription Type k Units (2021-2026)
  • Table 399. Mexico Retinal Drugs Sales, by Distribution Channel k Units (2021-2026)
  • Table 400. Retinal Drugs: by Type(USD/Units)
  • Table 401. Research Programs/Design for This Report
  • Table 402. Key Data Information from Secondary Sources
  • Table 403. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Retinal Drugs: by Type USD Million (2015-2020)
  • Figure 5. Global Retinal Drugs: by Prescription Type USD Million (2015-2020)
  • Figure 6. Global Retinal Drugs: by Distribution Channel USD Million (2015-2020)
  • Figure 7. South America Retinal Drugs Share (%), by Country
  • Figure 8. Asia Pacific Retinal Drugs Share (%), by Country
  • Figure 9. Europe Retinal Drugs Share (%), by Country
  • Figure 10. MEA Retinal Drugs Share (%), by Country
  • Figure 11. North America Retinal Drugs Share (%), by Country
  • Figure 12. Global Retinal Drugs: by Type k Units (2015-2020)
  • Figure 13. Global Retinal Drugs: by Prescription Type k Units (2015-2020)
  • Figure 14. Global Retinal Drugs: by Distribution Channel k Units (2015-2020)
  • Figure 15. South America Retinal Drugs Share (%), by Country
  • Figure 16. Asia Pacific Retinal Drugs Share (%), by Country
  • Figure 17. Europe Retinal Drugs Share (%), by Country
  • Figure 18. MEA Retinal Drugs Share (%), by Country
  • Figure 19. North America Retinal Drugs Share (%), by Country
  • Figure 20. Global Retinal Drugs: by Type USD/Units (2015-2020)
  • Figure 21. Global Retinal Drugs share by Players 2020 (%)
  • Figure 22. Global Retinal Drugs share by Players (Top 3) 2020(%)
  • Figure 23. Global Retinal Drugs share by Players (Top 5) 2020(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 26. Bayer AG (Germany) Revenue: by Geography 2020
  • Figure 27. F. Hoffmann-La Roche (Switzerland) Revenue, Net Income and Gross profit
  • Figure 28. F. Hoffmann-La Roche (Switzerland) Revenue: by Geography 2020
  • Figure 29. Bausch & Lomb (United States) Revenue, Net Income and Gross profit
  • Figure 30. Bausch & Lomb (United States) Revenue: by Geography 2020
  • Figure 31. Novartis International AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 32. Novartis International AG (Switzerland) Revenue: by Geography 2020
  • Figure 33. Regeneron Pharmaceuticals, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Regeneron Pharmaceuticals, Inc. (United States) Revenue: by Geography 2020
  • Figure 35. Johnson and Johnson Vision (United States) Revenue, Net Income and Gross profit
  • Figure 36. Johnson and Johnson Vision (United States) Revenue: by Geography 2020
  • Figure 37. Merck & Co. (United States) Revenue, Net Income and Gross profit
  • Figure 38. Merck & Co. (United States) Revenue: by Geography 2020
  • Figure 39. Shire Plc (Untied States) Revenue, Net Income and Gross profit
  • Figure 40. Shire Plc (Untied States) Revenue: by Geography 2020
  • Figure 41. Janssen Biotech, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 42. Janssen Biotech, Inc. (United States) Revenue: by Geography 2020
  • Figure 43. Teva Pharmaceutical Industries Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 44. Teva Pharmaceutical Industries Ltd. (Israel) Revenue: by Geography 2020
  • Figure 45. Global Retinal Drugs: by Type USD Million (2021-2026)
  • Figure 46. Global Retinal Drugs: by Prescription Type USD Million (2021-2026)
  • Figure 47. Global Retinal Drugs: by Distribution Channel USD Million (2021-2026)
  • Figure 48. South America Retinal Drugs Share (%), by Country
  • Figure 49. Asia Pacific Retinal Drugs Share (%), by Country
  • Figure 50. Europe Retinal Drugs Share (%), by Country
  • Figure 51. MEA Retinal Drugs Share (%), by Country
  • Figure 52. North America Retinal Drugs Share (%), by Country
  • Figure 53. Global Retinal Drugs: by Type k Units (2021-2026)
  • Figure 54. Global Retinal Drugs: by Prescription Type k Units (2021-2026)
  • Figure 55. Global Retinal Drugs: by Distribution Channel k Units (2021-2026)
  • Figure 56. South America Retinal Drugs Share (%), by Country
  • Figure 57. Asia Pacific Retinal Drugs Share (%), by Country
  • Figure 58. Europe Retinal Drugs Share (%), by Country
  • Figure 59. MEA Retinal Drugs Share (%), by Country
  • Figure 60. North America Retinal Drugs Share (%), by Country
  • Figure 61. Global Retinal Drugs: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Bayer AG (Germany)
  • F. Hoffmann-La Roche (Switzerland)
  • Bausch & Lomb (United States)
  • Novartis International AG (Switzerland)
  • Regeneron Pharmaceuticals, Inc. (United States)
  • Johnson and Johnson Vision (United States)
  • Merck & Co. (United States)
  • Shire Plc (Untied States)
  • Janssen Biotech, Inc. (United States)
  • Teva Pharmaceutical Industries Ltd. (Israel)
Additional players considered in the study are as follows:
Oxurion (Belgium) , Santen Pharmaceutical Co., Ltd. (Japan) , Bausch Health Companies Inc. (Canada)
Select User Access Type

Key Highlights of Report


Sep 2021 200 Pages 76 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Retinal Drugs Quantitative research analysis
Retinal Drugs Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Retinal Drugs market is expected to see a CAGR of 12.2% during projected year 2020 to 2026.
Top performing companies in the Global Retinal Drugs market are Bayer AG (Germany), F. Hoffmann-La Roche (Switzerland), Bausch & Lomb (United States), Novartis International AG (Switzerland), Regeneron Pharmaceuticals, Inc. (United States), Johnson and Johnson Vision (United States), Merck & Co. (United States), Shire Plc (Untied States), Janssen Biotech, Inc. (United States) and Teva Pharmaceutical Industries Ltd. (Israel), to name a few.
North America is dominating the Retinal Drugs Market.

Know More About Retinal Drugs Report?

Have a Query? Click Here

Other Related Reports

Veterinary Medicine Comprehensive Study by Type (Pharmaceuticals, Vaccines, Others), Application (Companion Animals, Farm Animals), Distribution Channel (Online, Offline), End User (Veterinary Clinic...
$ 3800
Tretinoin Drugs Comprehensive Study by Type (Oral, Injection), Application (Keratinization Disorders, Acute Promyelocytic Leukemia (APL), Others), End-users (Hospitals, Clinics, Others), Distribution...
$ 3350
Patent Medicine Comprehensive Study by Type (Product Patents, Process Patents), Application (Adult, Children), Drug Type (Solid Drug, Semi-Solid Drug, Liquid Drug, Gas/Aerosol Drug, Others), Disease ...
$ 3750
Over The Counter (OTC) Drugs Comprehensive Study by Type (Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Mineral, and Supplements (VMS), Weight Loss/Dietary Products, Ophthalm...
$ 3750
Intravenous (IV) Ibuprofen Comprehensive Study by Application (Pediatrics, Adults), Indication (Pain/Inflammatory, Fever), Form (Tablet, Capsule, Suspension, Other) Players and Region - Global Market...
$ 3500
Anticholinergic Drugs Comprehensive Study by Type (Synthetic Compounds, Natural, Semi-Synthetic Compounds), Application (Overactive Bladder, Parkinson’s Disease, Chronic Obstructive Pulmonary Disease...
$ 3650